Posttraumatic Stress Disorder and Likelihood of Hormone Therapy Use among Women in the Nurses' Health Study II: A 26-Year Prospective Analysis
Abstract
Posttraumatic stress disorder (PTSD) is associated with higher risk of certain chronic diseases, including ovarian cancer, but underlying mechanisms remain unclear. Although prior work has linked menopausal hormone therapy (MHT) use with elevated ovarian cancer risk, little research considers PTSD to likelihood of MHT use. We examined whether PTSD was prospectively associated with greater likelihood of initiating MHT use over 26 years.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Mar 01, 2021
- Source ID
- 10.1158/1055-9965.epi-20-1227
Entities
People
- Andrea Roberts
- Andrew Ratanatharathorn
- Eric B. Rimm
- Jennifer A. Sumner
- Karestan C. Koenen
- Kristen Nishimi
- Laura Kubzansky
- Lori B. Chibnik
- Rebecca B. Lawn
- Rebecca C. Thurston
- Shaili C Jha
- Shelley S. Tworoger
- Sun Jae Jung
- Yongjoo Kim
Organizations
- Columbia University
- H. Lee Moffitt Cancer Center & Research Institute
- Harvard Medical School
- Harvard T.H. Chan School of Public Health
- Harvard University
- Massachusetts General Hospital
- National Institute of Mental Health
- National Institutes of Health
- United States Department of Defense
- University of California
- University of Pittsburgh
- University of Pittsburgh School of Medicine
- Yonsei University